Iatrogenic hyperphosphatemia: a metabolic consideration in critical care medicine.

Hypophosphatemia and its consequences have received considerable attention due to their frequency and occurrence in a wide spectrum of clinical disorders.1–7 The cardiac, pulmonary, neurological, and hematological complications of hypophosphatemia offer ample justification for implementing therapy i